Позиція маленька. Чому ризик все одно може бути великим?
На перший погляд:
«Я відкрив позицію лише на $100. Це ж небагато».
Але сама сума позиції ще не показує реальний ризик.
Уявімо два рахунки:
$100 позиція на рахунку $10 000 → це лише 1% капіталу.
$100 позиція на рахунку $200 → це вже 50% капіталу.
Однакова позиція — але зовсім різний вплив на рахунок.
Є ще один нюанс — плече.
Позиція на $100 може бути відкритою з використанням $20 власного капіталу та плеча. Тоді навіть відносно невеликий рух ціни матиме набагато більший вплив саме на використану маржу.
Тому питання:
«Наскільки велика моя позиція?»
не завжди достатнє.
Важливіше дивитися на:
розмір позиції відносно всього капіталу; рівень плеча; скільки можна втратити при русі ціни проти тебе; умови самого інструменту.
Маленька позиція в доларах не завжди означає маленький ризик для твого рахунку.
Ризик потрібно оцінювати відносно капіталу, а не просто дивитися на цифру позиції.
У TradFi Perpetuals є ціна угоди. Але для розрахунку Mark Price Binance використовує не лише її.
На перший погляд здається логічним: якщо контракт торгується за певною ціною, саме її біржа й має використовувати.
Але у perpetual-контрактів механіка складніша.
Binance розраховує Mark Price через медіану трьох значень: Price 1, Price 2 та Contract Price.
І саме Price 2 нещодавно змінився.
З 31 серпня 2026 року для TradFi Perpetual Contracts Binance змінила основу його розрахунку: замість Moving Average за 30 секунд використовується середнє за 1 хвилину.
При цьому сам Mark Price продовжує розраховуватися як медіана Price 1, Price 2 та Contract Price.
Чому це цікаво?
Тому що навіть невелика зміна в методиці розрахунку показує важливу річ:
ціна, яку ти бачиш як останню угоду, і Mark Price — це різні величини.
Mark Price — це окремий розрахунковий показник, а не просто копія останньої угоди.
Тому, коли працюєш із TradFi Perpetuals, недостатньо дивитися лише на графік.
Важливо розуміти, як саме формується ціна, яку використовує механіка контракту.
І мені подобається саме цей момент у TradFi на Binance: за знайомою назвою акції стоїть зовсім інша ринкова інфраструктура.
Тут важлива не тільки ціна активу, а й те, як біржа її розраховує.
If the premium is fixed upfront, is it actually the full cost of an Alpha position?
It’s easy to treat the upfront premium as the cost of the position.
After all, TermMax defines Max Cost as the upfront premium — and as the maximum possible loss of the Alpha position.
But that answers one question:
How large can the position’s loss be?
It doesn’t necessarily answer another:
What are the broader economics of holding or executing the position?
TermMax separately documents option financing.
That financing is calculated using the option’s notional value, the AMM rate and the time the position is held. The AMM-based annual rate can also adjust dynamically.
And financing isn’t the only separate mechanism. TermMax also documents transaction, execution and exit-related costs that can apply depending on the scenario.
The important distinction is not:
premium + fees = a bigger maximum loss.
That would contradict what Max Cost is designed to represent.
The distinction is:
maximum-loss boundary vs. broader economic cost structure
So knowing the maximum loss upfront does not mean every economic cost associated with holding or executing the position is fixed upfront.
The useful distinction isn't cheap vs. expensive.
It’s understanding what the upfront number actually tells you — and what it doesn't.
A leveraged position can look cheaper or more expensive than expected for a reason that is easy to miss.
In TermMax, the borrowing rate is fixed when the position is formed.
But the important part is what that means for the position’s value.
TermMax finalizes the borrowing cost upfront. The future interest obligation is therefore already reflected in the GT’s value, rather than simply accumulating over time like interest in a conventional floating-rate money market.
That changes how I would read a leveraged position.
The right question is not only:
“What is the borrowing rate?”
It is also:
“How much of the financing cost is already embedded in the position I’m looking at?”
There is one more layer.
Before maturity, the borrower can either repay directly with debt tokens or use the corresponding FT to settle the debt.
If that FT is available at a sufficient discount, the FT route can potentially reduce the realized repayment cost.
So the contractual financing obligation is fixed.
But the economics of settling that obligation can still depend on the repayment route.
And on the other side of the position, the collateral may have its own income profile.
That means I would evaluate leverage through two separate questions:
What does the financing cost?
and
What does the collateral earn?
The fixed rate gives certainty on the first.
It does not, by itself, tell you the economic return of the whole position.
For me, that is the more useful way to read a leveraged TermMax position: separate the financing obligation from the economics generated by the collateral.
A fixed borrowing rate can make the debt predictable. The interesting question is whether the cheapest way to settle it stays predictable too.
In TermMax, a borrower has two repayment routes:
→ repay the debt directly with debt tokens → or buy the corresponding FT before maturity and use it to settle the debt.
That second route is where the economics get more interesting.
Before maturity, an FT can trade below its face value. And the relationship between the current market rate and the borrower's locked rate can affect whether that discount exists and how attractive the FT route becomes.
If market rates move above the rate the borrower originally locked, TermMax's documentation notes that the corresponding FT may be available at a discount, potentially making settlement cheaper.
But “potentially” matters.
The debt obligation itself hasn't changed. And a discount doesn't automatically mean the borrower saves money. The FT still has to be available at a sufficient discount for that repayment route to be economically preferable.
So fixed-rate borrowing gives you certainty about the rate.
It doesn't necessarily give you certainty about which way of settling that same obligation will be cheapest.
That distinction makes the repayment economics more interesting than the fixed rate alone.
$5.8B of Intel Foundry revenue. But how much of it is actually external demand?
INTCB is one of the bStocks we can use to get exposure to Intel.
At first glance, Intel Foundry's Q2 revenue looks like a large foundry business:
$5.765B, up 31% YoY.
But then I looked one layer deeper.
Only $293M came from external customers.
Most of the reported Foundry revenue was intersegment — tied to Intel's own internal manufacturing activity. Intel also reported a $2.089B operating loss for the segment.
That changed how I read the headline number.
Foundry revenue ≠ external foundry demand.
A segment can be large before its external customer business is.
So when I look at INTCB, I don't just want to know:
“How big is Intel Foundry?”
I want to know:
“How much of that business is actually being bought by outside customers?”
For me, that's a much more useful way to read a foundry story.
Revenue can grow 300%+ without shipment growth coming anywhere close to 300%.
MUB and SNDKB are both available as bStocks and sit in the broader semiconductor/memory universe.
So at first glance, it’s easy to group them into the same broader semiconductor growth story.
But look at what’s actually driving the numbers.
For Micron, DRAM revenue reached $31.3B in fiscal Q3, up 343% YoY and representing 76% of total revenue.
Yet DRAM bit shipments grew only in the low-20% range YoY, while DRAM ASPs increased in the low-260% range.
In other words, DRAM revenue growth wasn't simply about selling dramatically more bits.
SanDisk's latest quarter tells a similar story from a different angle.
Its fiscal Q4 revenue reached $8.97B, up 51% sequentially — with roughly one-third of the sequential increase coming from higher volume and two-thirds from higher pricing.
That made me rethink how I read “growth” when looking at bStocks.
The ticker tells me which company I'm getting exposure to.
But the headline growth number doesn't automatically tell me what is driving that exposure.
Two bStocks can sit in the same broad category while very different things drive their financial results.
Before comparing growth rates, ask what's underneath the growth.
When I first saw that eligible stocks can be converted into bStocks instantly, I thought the main benefit was obvious:
It saves time.
But the more I thought about it, the less that seemed to be the whole story.
If moving between a direct stock and a bStock doesn't require me to wait for a traditional conversion process, the decision itself starts to feel different.
I don't have to treat the switch as a decision that comes with a long waiting period.
I can choose the format that makes sense for what I want to do now — and change it later if that changes.
That made me look at the word “instant” differently.
It's not just about how quickly the conversion happens.
It's about how much friction there is in changing my decision.
So I started wondering:
Does instant conversion simply save time, or does it make switching between the two forms of exposure a different kind of decision?
For me, that's the more interesting part.
The value isn't only in getting from one form to another faster.
It's in making the choice between them easier to change.
If a bStock tracks a listed stock, is it the same financial product?
When I first looked at bStocks, I naturally made a simple connection.
If a bStock gives me exposure to a listed company, I assumed the product itself should be pretty similar to the stock I would buy through a traditional broker.
But that's where I realized I was mixing two different things.
A bStock can give me exposure to the same underlying company without being the listed equity itself.
It is a certificate product under the ADGM/FSRA framework, rather than the listed equity.
And that distinction matters.
Two products can give me exposure to the same company without being the same financial product.
That made me change the question I ask when looking at a bStock.
Not only:
“Which company am I getting exposure to?”
But also:
“What kind of financial product am I actually holding?”
I can compare the underlying exposure.
I can compare how the price moves.
But I shouldn't automatically assume that the two instruments are the same just because they give me exposure to the same company.
For me, that's one of the important distinctions to understand with tokenized assets.
Same underlying company doesn't necessarily mean the same financial product.